世界のアルドステロン症治療市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Aldosteronism Treatments Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12033 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、アルドステロン症治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アルドステロン症治療の種類別市場規模（外科的アルドステロン症治療、非外科的アルドステロン症治療）、用途別市場規模（病院、外来手術センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・アルドステロン症治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Novartis、Accord Healthcare、Merck ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：外科的アルドステロン症治療、非外科的アルドステロン症治療 ・用途別分析2016年-2026年：病院、外来手術センター、その他 ・アルドステロン症治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・アルドステロン症治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・アルドステロン症治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・アルドステロン症治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・アルドステロン症治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Aldosteronism Treatments market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Aldosteronism Treatments size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Aldosteronism Treatments market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Aldosteronism Treatments market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Surgical Aldosteronism Treatment
Non-Surgical Aldosteronism Treatment

Market segment by Application, can be divided into
Hospitals
Ambulatory Surgical Centers
Others

Market segment by players, this report covers
Pfizer
Novartis
Accord Healthcare
Merck

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Aldosteronism Treatments
1.2 Classification of Aldosteronism Treatments by Type
1.2.1 Overview: Global Aldosteronism Treatments Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Aldosteronism Treatments Revenue Market Share by Type in 2020
1.2.3 Surgical Aldosteronism Treatment
1.2.4 Non-Surgical Aldosteronism Treatment
1.3 Global Aldosteronism Treatments Market by Application
1.3.1 Overview: Global Aldosteronism Treatments Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Global Aldosteronism Treatments Market Size & Forecast
1.5 Global Aldosteronism Treatments Market Size and Forecast by Region
1.5.1 Global Aldosteronism Treatments Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Aldosteronism Treatments Market Size by Region, (2016-2021)
1.5.3 North America Aldosteronism Treatments Market Size and Prospect (2016-2026)
1.5.4 Europe Aldosteronism Treatments Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Aldosteronism Treatments Market Size and Prospect (2016-2026)
1.5.6 South America Aldosteronism Treatments Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Aldosteronism Treatments Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Aldosteronism Treatments Market Drivers
1.6.2 Aldosteronism Treatments Market Restraints
1.6.3 Aldosteronism Treatments Trends Analysis
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Aldosteronism Treatments Product and Solutions
2.1.4 Pfizer Aldosteronism Treatments Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Aldosteronism Treatments Product and Solutions
2.2.4 Novartis Aldosteronism Treatments Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Accord Healthcare
2.3.1 Accord Healthcare Details
2.3.2 Accord Healthcare Major Business
2.3.3 Accord Healthcare Aldosteronism Treatments Product and Solutions
2.3.4 Accord Healthcare Aldosteronism Treatments Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Accord Healthcare Recent Developments and Future Plans
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Aldosteronism Treatments Product and Solutions
2.4.4 Merck Aldosteronism Treatments Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Merck Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Aldosteronism Treatments Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Aldosteronism Treatments Players Market Share
3.2.2 Top 10 Aldosteronism Treatments Players Market Share
3.2.3 Market Competition Trend
3.3 Aldosteronism Treatments Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Aldosteronism Treatments Revenue and Market Share by Type (2016-2021)
4.2 Global Aldosteronism Treatments Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Aldosteronism Treatments Revenue Market Share by Application (2016-2021)
5.2 Aldosteronism Treatments Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Aldosteronism Treatments Revenue by Type (2016-2026)
6.2 North America Aldosteronism Treatments Revenue by Application (2016-2026)
6.3 North America Aldosteronism Treatments Market Size by Country
6.3.1 North America Aldosteronism Treatments Revenue by Country (2016-2026)
6.3.2 United States Aldosteronism Treatments Market Size and Forecast (2016-2026)
6.3.3 Canada Aldosteronism Treatments Market Size and Forecast (2016-2026)
6.3.4 Mexico Aldosteronism Treatments Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Aldosteronism Treatments Revenue by Type (2016-2026)
7.2 Europe Aldosteronism Treatments Revenue by Application (2016-2026)
7.3 Europe Aldosteronism Treatments Market Size by Country
7.3.1 Europe Aldosteronism Treatments Revenue by Country (2016-2026)
7.3.2 Germany Aldosteronism Treatments Market Size and Forecast (2016-2026)
7.3.3 France Aldosteronism Treatments Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Aldosteronism Treatments Market Size and Forecast (2016-2026)
7.3.5 Russia Aldosteronism Treatments Market Size and Forecast (2016-2026)
7.3.6 Italy Aldosteronism Treatments Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Aldosteronism Treatments Revenue by Type (2016-2026)
8.2 Asia-Pacific Aldosteronism Treatments Revenue by Application (2016-2026)
8.3 Asia-Pacific Aldosteronism Treatments Market Size by Region
8.3.1 Asia-Pacific Aldosteronism Treatments Revenue by Region (2016-2026)
8.3.2 China Aldosteronism Treatments Market Size and Forecast (2016-2026)
8.3.3 Japan Aldosteronism Treatments Market Size and Forecast (2016-2026)
8.3.4 South Korea Aldosteronism Treatments Market Size and Forecast (2016-2026)
8.3.5 India Aldosteronism Treatments Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Aldosteronism Treatments Market Size and Forecast (2016-2026)
8.3.7 Australia Aldosteronism Treatments Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Aldosteronism Treatments Revenue by Type (2016-2026)
9.2 South America Aldosteronism Treatments Revenue by Application (2016-2026)
9.3 South America Aldosteronism Treatments Market Size by Country
9.3.1 South America Aldosteronism Treatments Revenue by Country (2016-2026)
9.3.2 Brazil Aldosteronism Treatments Market Size and Forecast (2016-2026)
9.3.3 Argentina Aldosteronism Treatments Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Aldosteronism Treatments Revenue by Type (2016-2026)
10.2 Middle East & Africa Aldosteronism Treatments Revenue by Application (2016-2026)
10.3 Middle East & Africa Aldosteronism Treatments Market Size by Country
10.3.1 Middle East & Africa Aldosteronism Treatments Revenue by Country (2016-2026)
10.3.2 Turkey Aldosteronism Treatments Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Aldosteronism Treatments Market Size and Forecast (2016-2026)
10.3.4 UAE Aldosteronism Treatments Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Aldosteronism Treatments Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Aldosteronism Treatments Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Aldosteronism Treatments Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Aldosteronism Treatments Revenue (USD Million) by Region (2016-2021)
Table 5. Global Aldosteronism Treatments Revenue Market Share by Region (2021-2026)
Table 6. Pfizer Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Major Business
Table 8. Pfizer Aldosteronism Treatments Product and Solutions
Table 9. Pfizer Aldosteronism Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Aldosteronism Treatments Product and Solutions
Table 13. Novartis Aldosteronism Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Accord Healthcare Corporate Information, Head Office, and Major Competitors
Table 15. Accord Healthcare Major Business
Table 16. Accord Healthcare Aldosteronism Treatments Product and Solutions
Table 17. Accord Healthcare Aldosteronism Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Merck Corporate Information, Head Office, and Major Competitors
Table 19. Merck Major Business
Table 20. Merck Aldosteronism Treatments Product and Solutions
Table 21. Merck Aldosteronism Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Global Aldosteronism Treatments Revenue (USD Million) by Players (2019-2021)
Table 23. Global Aldosteronism Treatments Revenue Share by Players (2019-2021)
Table 24. Breakdown of Aldosteronism Treatments by Company Type (Tier 1, Tier 2 and Tier 3)
Table 25. Aldosteronism Treatments Players Head Office, Products and Services Provided
Table 26. Aldosteronism Treatments Mergers & Acquisitions in the Past Five Years
Table 27. Aldosteronism Treatments New Entrants and Expansion Plans
Table 28. Global Aldosteronism Treatments Revenue (USD Million) by Type (2016-2021)
Table 29. Global Aldosteronism Treatments Revenue Share by Type (2016-2021)
Table 30. Global Aldosteronism Treatments Revenue Forecast by Type (2021-2026)
Table 31. Global Aldosteronism Treatments Revenue by Application (2016-2021)
Table 32. Global Aldosteronism Treatments Revenue Forecast by Application (2021-2026)
Table 33. North America Aldosteronism Treatments Revenue by Type (2016-2021) & (USD Million)
Table 34. North America Aldosteronism Treatments Revenue by Type (2021-2026) & (USD Million)
Table 35. North America Aldosteronism Treatments Revenue by Application (2016-2021) & (USD Million)
Table 36. North America Aldosteronism Treatments Revenue by Application (2021-2026) & (USD Million)
Table 37. North America Aldosteronism Treatments Revenue by Country (2016-2021) & (USD Million)
Table 38. North America Aldosteronism Treatments Revenue by Country (2021-2026) & (USD Million)
Table 39. Europe Aldosteronism Treatments Revenue by Type (2016-2021) & (USD Million)
Table 40. Europe Aldosteronism Treatments Revenue by Type (2021-2026) & (USD Million)
Table 41. Europe Aldosteronism Treatments Revenue by Application (2016-2021) & (USD Million)
Table 42. Europe Aldosteronism Treatments Revenue by Application (2021-2026) & (USD Million)
Table 43. Europe Aldosteronism Treatments Revenue by Country (2016-2021) & (USD Million)
Table 44. Europe Aldosteronism Treatments Revenue by Country (2021-2026) & (USD Million)
Table 45. Asia-Pacific Aldosteronism Treatments Revenue by Type (2016-2021) & (USD Million)
Table 46. Asia-Pacific Aldosteronism Treatments Revenue by Type (2021-2026) & (USD Million)
Table 47. Asia-Pacific Aldosteronism Treatments Revenue by Application (2016-2021) & (USD Million)
Table 48. Asia-Pacific Aldosteronism Treatments Revenue by Application (2021-2026) & (USD Million)
Table 49. Asia-Pacific Aldosteronism Treatments Revenue by Region (2016-2021) & (USD Million)
Table 50. Asia-Pacific Aldosteronism Treatments Revenue by Region (2021-2026) & (USD Million)
Table 51. South America Aldosteronism Treatments Revenue by Type (2016-2021) & (USD Million)
Table 52. South America Aldosteronism Treatments Revenue by Type (2021-2026) & (USD Million)
Table 53. South America Aldosteronism Treatments Revenue by Application (2016-2021) & (USD Million)
Table 54. South America Aldosteronism Treatments Revenue by Application (2021-2026) & (USD Million)
Table 55. South America Aldosteronism Treatments Revenue by Country (2016-2021) & (USD Million)
Table 56. South America Aldosteronism Treatments Revenue by Country (2021-2026) & (USD Million)
Table 57. Middle East & Africa Aldosteronism Treatments Revenue by Type (2016-2021) & (USD Million)
Table 58. Middle East & Africa Aldosteronism Treatments Revenue by Type (2021-2026) & (USD Million)
Table 59. Middle East & Africa Aldosteronism Treatments Revenue by Application (2016-2021) & (USD Million)
Table 60. Middle East & Africa Aldosteronism Treatments Revenue by Application (2021-2026) & (USD Million)
Table 61. Middle East & Africa Aldosteronism Treatments Revenue by Country (2016-2021) & (USD Million)
Table 62. Middle East & Africa Aldosteronism Treatments Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Aldosteronism Treatments Picture
Figure 2. Global Aldosteronism Treatments Revenue Market Share by Type in 2020
Figure 3. Surgical Aldosteronism Treatment
Figure 4. Non-Surgical Aldosteronism Treatment
Figure 5. Aldosteronism Treatments Revenue Market Share by Application in 2020
Figure 6. Hospitals Picture
Figure 7. Ambulatory Surgical Centers Picture
Figure 8. Others Picture
Figure 9. Global Aldosteronism Treatments Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Aldosteronism Treatments Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Aldosteronism Treatments Revenue Market Share by Region (2016-2026)
Figure 12. Global Aldosteronism Treatments Revenue Market Share by Region in 2020
Figure 13. North America Aldosteronism Treatments Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Aldosteronism Treatments Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Aldosteronism Treatments Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Aldosteronism Treatments Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Aldosteronism Treatments Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Aldosteronism Treatments Market Drivers
Figure 19. Aldosteronism Treatments Market Restraints
Figure 20. Aldosteronism Treatments Market Trends
Figure 21. Pfizer Recent Developments and Future Plans
Figure 22. Novartis Recent Developments and Future Plans
Figure 23. Accord Healthcare Recent Developments and Future Plans
Figure 24. Merck Recent Developments and Future Plans
Figure 25. Global Aldosteronism Treatments Revenue Share by Players in 2020
Figure 26. Aldosteronism Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 27. Global Top 3 Players Aldosteronism Treatments Revenue Market Share in 2020
Figure 28. Global Top 10 Players Aldosteronism Treatments Revenue Market Share in 2020
Figure 29. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 30. Global Aldosteronism Treatments Revenue Share by Type in 2020
Figure 31. Global Aldosteronism Treatments Market Share Forecast by Type (2021-2026)
Figure 32. Global Aldosteronism Treatments Revenue Share by Application in 2020
Figure 33. Global Aldosteronism Treatments Market Share Forecast by Application (2021-2026)
Figure 34. North America Aldosteronism Treatments Sales Market Share by Type (2016-2026)
Figure 35. North America Aldosteronism Treatments Sales Market Share by Application (2016-2026)
Figure 36. North America Aldosteronism Treatments Revenue Market Share by Country (2016-2026)
Figure 37. United States Aldosteronism Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 38. Canada Aldosteronism Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 39. Mexico Aldosteronism Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Europe Aldosteronism Treatments Sales Market Share by Type (2016-2026)
Figure 41. Europe Aldosteronism Treatments Sales Market Share by Application (2016-2026)
Figure 42. Europe Aldosteronism Treatments Revenue Market Share by Country (2016-2026)
Figure 43. Germany Aldosteronism Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. France Aldosteronism Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. United Kingdom Aldosteronism Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Russia Aldosteronism Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Italy Aldosteronism Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Aldosteronism Treatments Sales Market Share by Type (2016-2026)
Figure 49. Asia-Pacific Aldosteronism Treatments Sales Market Share by Application (2016-2026)
Figure 50. Asia-Pacific Aldosteronism Treatments Revenue Market Share by Region (2016-2026)
Figure 51. China Aldosteronism Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Japan Aldosteronism Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. South Korea Aldosteronism Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. India Aldosteronism Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Southeast Asia Aldosteronism Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Australia Aldosteronism Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South America Aldosteronism Treatments Sales Market Share by Type (2016-2026)
Figure 58. South America Aldosteronism Treatments Sales Market Share by Application (2016-2026)
Figure 59. South America Aldosteronism Treatments Revenue Market Share by Country (2016-2026)
Figure 60. Brazil Aldosteronism Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Argentina Aldosteronism Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Middle East and Africa Aldosteronism Treatments Sales Market Share by Type (2016-2026)
Figure 63. Middle East and Africa Aldosteronism Treatments Sales Market Share by Application (2016-2026)
Figure 64. Middle East and Africa Aldosteronism Treatments Revenue Market Share by Country (2016-2026)
Figure 65. Turkey Aldosteronism Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Saudi Arabia Aldosteronism Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. UAE Aldosteronism Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Methodology
Figure 69. Research Process and Data Source

---